BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

532391

OPTOCIRCUI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

OPTO CIRCUITS (INDIA) LTD. Share Price Update

As of the latest trading session, OPTO CIRCUITS (INDIA) LTD. share price is currently at ₹ 1.78, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 1.78 and ₹ 1.94. Over the past year, OPTO CIRCUITS (INDIA) LTD. has achieved a return of -59.17 %. In the last month alone, the return has been -16.43 %. Read More...

OPTO CIRCUITS (INDIA) LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

OPTO CIRCUITS (INDIA) LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2022 (Values in Cr)
Revenue 0.02
Operating Expense 13.94
Net Profit -155.43
Net Profit Margin (%) -777150.00
Earnings Per Share (EPS) -5.17
EBITDA -155.43
Effective Tax Rate (%) 0.00
Particulars DEC 2021 (Values in Cr)
Revenue 0.02
Operating Expense 0.89
Net Profit -0.87
Net Profit Margin (%) -4350.00
Earnings Per Share (EPS) -0.03
EBITDA -0.87
Effective Tax Rate (%) 0.00
Particulars SEP 2021 (Values in Cr)
Revenue 0.11
Operating Expense 0.00
Net Profit -1.22
Net Profit Margin (%) -1109.09
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2021 (Values in Cr)
Revenue 0.09
Operating Expense 1.39
Net Profit -1.28
Net Profit Margin (%) -1422.22
Earnings Per Share (EPS) -0.04
EBITDA -1.28
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.09
Operating Expense 2.11
Net Profit -2.00
Net Profit Margin (%) -2222.22
Earnings Per Share (EPS) -0.07
EBITDA -2.00
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.25
Operating Expense 17.55
Net Profit -158.80
Net Profit Margin (%) -63520.00
Earnings Per Share (EPS) -5.28
EBITDA -158.80
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.38
Operating Expense 13.17
Net Profit -2.74
Net Profit Margin (%) -32.69
Earnings Per Share (EPS) -0.09
EBITDA -1.70
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 62.61
Operating Expense 49.92
Net Profit -1191.52
Net Profit Margin (%) -1903.08
Earnings Per Share (EPS) -39.63
EBITDA -1187.41
Effective Tax Rate (%) 0.00
Particulars MAR 2019 (Values in Cr)
Revenue 104.82
Operating Expense 73.06
Net Profit 34.92
Net Profit Margin (%) 33.31
Earnings Per Share (EPS) 1.20
EBITDA 44.88
Effective Tax Rate (%) 0.00
Particulars MAR 2018 (Values in Cr)
Revenue 63.46
Operating Expense 53.70
Net Profit 10.01
Net Profit Margin (%) 15.77
Earnings Per Share (EPS) 0.39
EBITDA 20.42
Effective Tax Rate (%) 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 32.54
ROE % 4.70
ROCE % 2.86
Total Debt to Total Equity 0.94
EBITDA Margin 26.54
Particulars MAR 2018 (Values in Cr)
Book Value / Share 27.85
ROE % 3.97
ROCE % 2.24
Total Debt to Total Equity 1.21
EBITDA Margin 24.01
Particulars MAR 2017 (Values in Cr)
Book Value / Share 29.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.87
EBITDA Margin 11.27
Particulars MAR 2016 (Values in Cr)
Book Value / Share 69.67
ROE % -1.82
ROCE % 0.35
Total Debt to Total Equity 0.80
EBITDA Margin 16.96
Particulars MAR 2015 (Values in Cr)
Book Value / Share 80.57
ROE % 0.64
ROCE % 4.25
Total Debt to Total Equity 0.81
EBITDA Margin 21.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.84
EBITDA Margin 31.54
Particulars MAR 2019 (Values in Cr)
Book Value / Share 39.14
ROE % 3.04
ROCE % 2.10
Total Debt to Total Equity 0.47
EBITDA Margin 42.83
Particulars MAR 2018 (Values in Cr)
Book Value / Share 39.07
ROE % 0.99
ROCE % 0.68
Total Debt to Total Equity 0.63
EBITDA Margin 32.19
Particulars MAR 2017 (Values in Cr)
Book Value / Share 36.82
ROE % -0.14
ROCE % 0.34
Total Debt to Total Equity 0.66
EBITDA Margin 30.11
Particulars MAR 2016 (Values in Cr)
Book Value / Share 52.29
ROE % -1.41
ROCE % 0.66
Total Debt to Total Equity 0.63
EBITDA Margin 30.60
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 1106.28
Total Liabilities 1106.28
Total Equity -86.01
Share Outstanding 300625744
Price to Book Ratio 1.30
Return on Assets (%) -123.64
Return on Capital (%) -151.76
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 4.40
Total Assets 2153.06
Total Liabilities 2153.06
Total Equity 1171.89
Share Outstanding 300625744
Price to Book Ratio 0.21
Return on Assets (%) 2.38
Return on Capital (%) 2.6
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 11.16
Total Assets 2013.11
Total Liabilities 2013.11
Total Equity 954.48
Share Outstanding 287495406
Price to Book Ratio 0.20
Return on Assets (%) 1.71
Return on Capital (%) 1.93
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 8.39
Total Assets 2186.38
Total Liabilities 2186.38
Total Equity 867.23
Share Outstanding 242319407
Price to Book Ratio 0.25
Return on Assets (%) -23.32
Return on Capital (%) -27.84
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 9.55
Total Assets 3212.49
Total Liabilities 3212.49
Total Equity 1706.49
Share Outstanding 242319407
Price to Book Ratio 0.19
Return on Assets (%) -1.16
Return on Capital (%) -1.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 643.91
Total Liabilities 643.91
Total Equity 39.02
Share Outstanding 300625744
Price to Book Ratio 1.30
Return on Assets (%) -185.04
Return on Capital (%) -225.71
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.21
Total Assets 1823.88
Total Liabilities 1823.88
Total Equity 1176.50
Share Outstanding 300625744
Price to Book Ratio 0.21
Return on Assets (%) 1.91
Return on Capital (%) 2.06
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.96
Total Assets 1774.48
Total Liabilities 1774.48
Total Equity 1123.30
Share Outstanding 287495406
Price to Book Ratio 0.20
Return on Assets (%) 0.56
Return on Capital (%) 0.6
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 1702.07
Total Liabilities 1702.07
Total Equity 892.32
Share Outstanding 242319407
Price to Book Ratio 0.25
Return on Assets (%) -21.38
Return on Capital (%) -22.78
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 2.76
Total Assets 2258.23
Total Liabilities 2258.23
Total Equity 1266.97
Share Outstanding 242319407
Price to Book Ratio 0.19
Return on Assets (%) -0.79
Return on Capital (%) -0.92
Particulars MAR 2020 (Values in Cr)
Net Income -1379.41
Cash from Operations 72.26
Cash from Investing -149.51
Cash from Financing 75.88
Net change in Cash -1.36
Free Cash Flow 72.75
Particulars MAR 2019 (Values in Cr)
Net Income 53.79
Cash from Operations 45.17
Cash from Investing 17.18
Cash from Financing -69.11
Net change in Cash -6.75
Free Cash Flow 46.26
Particulars MAR 2020 (Values in Cr)
Net Income -1191.52
Cash from Operations 21.30
Cash from Investing 18.96
Cash from Financing -41.16
Net change in Cash -0.90
Free Cash Flow 21.32
Particulars MAR 2019 (Values in Cr)
Net Income 34.92
Cash from Operations 41.95
Cash from Investing -11.42
Cash from Financing -30.29
Net change in Cash 0.24
Free Cash Flow 42.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 76.41 13.35 100103.60 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 75.38 183.85 4.73 141.28 51.01 / 98.70
SHREE PACETRONIX LTD. 70.00 14.58 1.87 25.20 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.68 0.00 2.57 27.88 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 83.30 12.22 100103.60 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 32.25 0.00 -17.27 24.09 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5560.50 29.47 6.24 6083.19 3750.00 / 6400.00

OPTO CIRCUITS (INDIA) LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1.78 -4.81 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

-

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

-16.43%

down

Over 1 Year

-59.17%

down

Over 3 Months

-33.08%

down

Over 3 Years

-36.61%

down

Over 6 Months

-37.54%

down

Over 5 Years

-28.61%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

OPTO CIRCUITS (INDIA) LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
79.53%
Promoter Holdings
18.51%
FII
0.96%
DII
0.97%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Vinod Parasram Ramnani 3.6358581E7 (12.09%) Shareholding of Promoter and Promoter Group
Usha Vinod Ramnani 1.0777176E7 (3.58%) Shareholding of Promoter and Promoter Group
Gobind Gumnani 8700835.0 (2.89%) Public Shareholding
Jayesh Patel 8442971.0 (2.81%) Shareholding of Promoter and Promoter Group
Valiveti Bhaskar 5776295.0 (1.92%) Public Shareholding
Avina G Gumnani 5725419.0 (1.9%) Public Shareholding
Anna Thomas Chacko 4947098.0 (1.65%) Public Shareholding
Thomas Dietiker 94589.0 (0.03%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

OPTO CIRCUITS (INDIA) LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2012 3.0 Final 25 Sep 2012 Equity shares
21 Sep 2011 4.5 Final 23 Sep 2011 Equity shares
21 Sep 2010 4.0 Final 23 Sep 2010 Equity shares
18 Sep 2009 4.0 Final 23 Sep 2009 Equity shares
24 Sep 2008 5.0 Final 26 Sep 2008 Equity shares
18 Sep 2007 5.0 Final 20 Sep 2007 Equity shares
08 Jul 2005 0.0 Final 12 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
31 Mar 2012 29 Mar 2012 3:10
04 Nov 2008 03 Nov 2008 7:10
26 Oct 2007 25 Oct 2007 1:2
31 Oct 2006 30 Oct 2006 1:1
17 Aug 2005 16 Aug 2005 5:10
21 Oct 2004 20 Oct 2004 3:10
11 Nov 2003 10 Nov 2003 2:10
16 Jan 2003 14 Jan 2003 1:10
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

OPTO CIRCUITS (INDIA) LTD. Share Price

Opto Circuits (India) Limited, a three star export-trading house was established in June 8, 1992 as a private limited company. Opto maintaining the strict quality control by benchmarking the facilities and the products to the international standards. Accordingly the company has been accredited with ISO 9001 certification since 1995 by RVA, Netherlands, through STQC Directorate, Govt. of India. It operates in the medical electronics space and manufactures optical sensors, security systems and optoelectronic equipment. The company also undertakes design of optoelectronic devices. It also manufactures a range of healthcare equipment like pulse oximeter, multi parameter monitors, pulse oximeter sensors, digital thermometers, cholesterol monitors and fluid warmers. Opto is a recognized export house and has CE and FDA approvals for many of its products. The Company's clients include Philips Medizine Systems, General Electric Medical Systems, Life Stream Technologies etc., and hospitals like Apollo, Escorts, Breach Candy, Lilavati and Wockhardt.

Opto's status was refreshed as a public limited company in April of the year 2000. In the year 2001, the company had acquired controlling stake in Advanced Micronic Devices Limited, a company engaged in the business of Health care. During the year 2002, Opto Circuits had entered into an agreement with Hindustan Lever to buy the business line of Digital Thermometers. During the period of 2002-03, it had acquired the Patient Monitoring Division of Palco Laboratories Inc a leading US based company and also in the year 2003, the company had set up its 100% subsidiary under the name of Mediaid Inc in US. During the year 2004, Opto had acquired the 100% stake in Altron. The year 2005 was a quantum leap in the company's saga, Opto Had diversified from non-invasive segment to invasive segment of the healthcare domain. In the same year 2005, the company had acquired a Eurocor Gmbh, German. The Company's Eurocor had signed distribution agreement with Fumedica, AG in the year 2006 and also in same year, Mediaid received FDA approval for SpO2 sensor range. . The Company had inked purchase agreements in April of the year 2007 to acquire medical equipment companies in India, namely, Devon Innovations and Ormed Medical Technology. In September of the year 2007, Opto Circuits had entered into technology transfer agreement with Elpro Srl - Italy, to develop, manufacture and market different variants of electro cardio graph machines (ECG machines). From the November 2007, the company's status upgraded from two star export trading house to three star export trading house in accordance with the provisions of EXIM policy, from ministry of commerce and industry, government of India.

As at April 2008, Opto Circuits had completed acquisition of Criticare Systems, a leading US-based healthcare company. Subsequently Criticare Systems became a wholly owned subsidiary of the company with effective from 10th April 2008. The Company had received approval from the US Food and Drug Administration (US FDA) in May of the year 2008 to market two of its products in the country. The model 900 and model 960 vital sign monitors are the first Opto bedside monitors to receive the approval from the US FDA.

During July 2007, the Company made a preferential issue of 11,64,520 shares at the rate of Rs.360/- per share to Lehman Brothers Asia Limited and Alliance Bernstein Limited, Foreign Institutional Investors (FIIs). 11,00,000 Share Warrants were also issued to the promoters, directors of subsidiary companies & employees which were fully convertible into Equity Shares of the Company at the rate of Rs.360/- per share with in a period of 18 months from the date of allotment.

As on 31st March 2008 Company had six subsidiary companies, namely, Advanced Micronic Devices Limited, a listed company, Mediaid Inc, USA, Altron Industries Private Limited, Eurocor GmbH, Germany, Devon Innovations Private Limited and Ormed Medical Technology Limited.

Devon Innovations Private Ltd., and Ormed Medical Technologies Ltd., were acquired during the year 2007-08. by Investing Rs.312.50 Lacs and Rs.85.01 Lacs respectively and resulting to acquisitions, these Companies became wholly owned subsidiaries of Company.
Criticare Systems Inc., a US based Company was acquired in April, 2008 which resultant became a wholly owned subsidiary of Company. The Company, subsequent to 31st March 2010 incorporated a wholly owned subsidiary in Malaysia viz. Opto Circuits (Malaysia) SDN BHD and acquired N. S. Remedies Pvt. Ltd., in India and Unetixs Vascular Inc. in USA. The Company allotted 15,00,000 Convertible Share Warrants to an NRI on 9th April, 2010 against the amount received during the Financial Year 2009-10. Further, on 15th September 2009, it allotted 2,14,30,484 Equity Shares under Qualified Institutional Placements at Rs.186.65 per Share.

In 2010-2011, the Company acquired 100% of the capital stock of US-based Unetixs Vascular, Inc., a specialist in detection of peripheral arterial disease (PAD). It acquired Kolkata (India) based N.S. Remedies Pvt. Ltd.

During the year 2010-11, the Company acquired three companies (one domestic and two overseas) which comprised of N.S. Remedies Pvt. Ltd., an advanced stent manufacturing company based in West Bengal, India; Unetixs Vascular Inc., a specialist in vascular diagnostics based in Rhode Island, USA and Cardiac Science Corporation, owner of reputed cardiology product brands like Quinton, Burdick and Powerheart based in Washington, USA. Altron Industries Pvt. Ltd., an Opto Circuits subsidiary, was renamed Opto Eurocor Healthcare Ltd. during the year 2010 - 2011.

During the year 2010-11, the Company, through its subsidiaries, Criticare Systems, Inc. , Mediaid, Inc. and Eurocor GmbH made investments into Criticare - Malaysia, Mediaid - Dubai and Eurocor - Malaysia respectively, which were rendered as wholly owned subsidiaries and thereby the step-down subsidiaries of Opto Circuits (India) Limited. Advanced Micronic Devices Ltd. (AMDL) transferred its investment in Micronic Healthcare Pvt. Ltd., to Opto Infrastructure Ltd. (OIL), for a value of Rs. 1 lac. Opto Eurocor Healthcare Ltd. (OEHL) transferred the assets net of liabilities related to the Company's hotel line of business for a value of Rs 60 to Micronic Healthcare Pvt. Ltd. (MHPL), a wholly owned subsidiary of Opto Infrastructure Ltd. (OIL) and consequently, MHPL became the owner of such assets.

During 2011, investments of three US-based subsidiaries: Cardiac Science Corporation, Criticare Systems Inc. and Unetixs Vascular, Inc., were transferred to Opto Cardiac Care Ltd. Investments of subsidiaries, Eurocor GmbH and N.S. Remedies Pvt. Ltd. were transferred to Opto Eurocor Healthcare Ltd. Both Opto Cardiac Care Ltd. and Opto Eurocor Healthcare Ltd. were wholly owned subsidiaries of Opto Circuits (India) Ltd.

On 31st March 2012, the Board of Directors of the Company allotted 55,919,863 Bonus Equity Shares of Rs 10/- each in the ratio of 3:10 to the Members, which consequently were listed on the National Stock Exchange of India Limited (NSE) and the Bombay Stock Exchange Limited (BSE).

Parent organization Indian Private
NSE symbol OPTOCIRCUI
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Opto Circuits (India) Ltd?

Answer Field

The share price of Opto Circuits (India) Ltd for NSE is ₹ 1.80 and for BSE is ₹ 1.78.

What is the Market Cap of Opto Circuits (India) Ltd?

Answer Field

The market cap of Opto Circuits (India) Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Opto Circuits (India) Ltd?

Answer Field

The 52 Week High and Low of Opto Circuits (India) Ltd for NSE is ₹ 1.85 and ₹ 0.00 and for BSE is ₹ 1.94 and ₹ 0.00.

How to Buy Opto Circuits (India) Ltd share?

Answer Field

You can trade in Opto Circuits (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Opto Circuits (India) Ltd?

Answer Field

The 1 year returns on the stock has been -59.17%.

What is the Current Share Price of Opto Circuits (India) Ltd?

Answer Field

Opto Circuits (India) Ltd share price is for NSE ₹ 1.80 & for BSE ₹ 1.78 as on May 23 2022 12:00 AM.

What is the Market Cap of Opto Circuits (India) Ltd Share?

Answer Field

The market cap of Opto Circuits (India) Ltd for NSE ₹ 0.0 & for BSE ₹ 0.0 as on May 23 2022 12:00 AM.

What is the P/E Ratio of Opto Circuits (India) Ltd Share?

Answer Field

As on May 23 2022 12:00 AM the price-to-earnings (PE) ratio for Opto Circuits (India) Ltd share is 0.0.

What is the PB ratio of Opto Circuits (India) Ltd Share?

Answer Field

As on May 23 2022 12:00 AM, the price-to-book (PB) ratio for Opto Circuits (India) Ltd share is 0.0.

How to Buy Opto Circuits (India) Ltd Share?

Answer Field

You can trade in Opto Circuits (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Opto Circuits (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Opto Circuits (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Opto Circuits (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|